In fact, S.H.I.E.L.D. Group's profitability was already extremely formidable. Whether it was S.H.I.E.L.D. Auto, S.H.I.E.L.D. Technology, S.H.I.E.L.D. Bio, or S.H.I.E.L.D. Aerospace, their annual profits rivaled those of Fortune 500 companies—and ranked among the highest. Even S.H.I.E.L.D. Film, relying solely on the box office earnings of The Dark Knight, had already made billions of dollars in profit. Chen Mo simply did not lack money.
Now, aside from continuing to develop S.H.I.E.L.D. Group and accomplish some of his goals, Chen Mo also wanted to do more for this world. Supporting the Ocean Guardian Association was one such effort.
Previously, S.H.I.E.L.D. Bio had launched a new anti-cancer drug that saved countless cancer patients and rescued the lives of over a hundred million people.
After that, S.H.I.E.L.D. Bio successively introduced several other highly effective medicines targeting AIDS, high blood pressure, diabetes, hepatitis B, pneumonia, arthritis, and many other diseases. While these medicines were not as powerful as the anti-cancer drug, they were still far more effective than any existing drugs in the real world.
Moreover, compared with the exorbitant prices of similar drugs sold by other pharmaceutical companies, S.H.I.E.L.D. Bio continued to uphold its longstanding principle: ensuring that every patient could afford treatment without it becoming too great a burden on their lives or driving them into bankruptcy.
In the eyes of many patients and ordinary people, S.H.I.E.L.D. Bio was completely different from those pharmaceutical companies that, driven by money, mercilessly squeezed patients dry. To them, S.H.I.E.L.D. Bio was more like a charitable organization.
Its medicines worked better, yet their prices were extremely low, and people had even worried that S.H.I.E.L.D. Bio might be losing money.
Chen Mo's original intention had been to benefit humanity in the real world. Compared to the outrageous profits of other pharmaceutical companies, S.H.I.E.L.D. Bio's profit margins were indeed